General Commentary

Published on 07 Nov 2024

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study

in Cancer Immunity and Immunotherapy

Mehmet Fatih Ozbay

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476215

222 views

Review

Accepted on 06 Nov 2024

Targeting extracellular matrix stiffness for cancer therapy

in Cancer Immunity and Immunotherapy

Xiuqing Feng
Fujun Cao
Xiangji Wu
Ping Wang
Hong Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467602

138 views

Original Research

Accepted on 06 Nov 2024

The Close Association of Muribaculum and PA (10:0/a-17:0) with the Occurrence of Pancreatic Ductal Adenocarcinoma and Immunotherapy

in Cancer Immunity and Immunotherapy

Enzhao Wang
Kuiwu Ren
Xiangyu Wang
Sen Du
Xiang Gao
Wang Niu
Chenyue Guan
Xue Liu
Panpan Wu
Chunlong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505966

Original Research

Accepted on 06 Nov 2024

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Luigi Liguori
Gabriele Giorgio
Giovanna Polcaro
Valentina Pagliara
Domenico Malandrino
Francesco Perri
Marco Cascella
Alessandro Ottaiano
Valeria Conti
Alberto Servetto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419544

Original Research

Published on 06 Nov 2024

Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study

in Cancer Immunity and Immunotherapy

Jiaqing Liu
Dongchen Sun
Shuoyu Xu
Jiayi Shen
Wenjuan Ma
Huaqiang Zhou
Yuxiang Ma
Yaxiong Zhang
Wenfeng Fang
Yuanyuan Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485703

530 views

Original Research

Published on 06 Nov 2024

A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma

in Cancer Immunity and Immunotherapy

Yizhuo Wang
Xin Wang
Yang Liu
Jiayuan Xu
Jiyuan Zhu
Yufu Zheng
Quan Qi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467052

690 views

Case Report

Published on 06 Nov 2024

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

in Cancer Immunity and Immunotherapy

Chenghao Fu
Haonan Du
Qiang Wang
Weiyou Zhu
Guangli Bian
Zhujuan Zhong
Yuheng Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452195

397 views

Review

Published on 06 Nov 2024

Tertiary lymphoid structures in ovarian cancer

in Cancer Immunity and Immunotherapy

Guojuan Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465516

417 views

Mini Review

Published on 06 Nov 2024

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

in Cancer Immunity and Immunotherapy

Yexin Zhou
Shanshan Wei
Menghui Xu
Xinhui Wu
Wenbo Dou
Huakang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489649

839 views

Mini Review

Published on 06 Nov 2024

Neoantigen prioritization based on antigen processing and presentation

in Cancer Immunity and Immunotherapy

Serina Tokita
Takayuki Kanaseki
Toshihiko Torigoe

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487378

430 views

Original Research

Accepted on 05 Nov 2024

Intratumoral delivery of mRNA encoding the endogenous TLR2/6 agonist UNE-C1 induces immunogenic cell death and enhances antitumor activity

in Cancer Immunity and Immunotherapy

Uijoo Kim
Sunkyo Hwang
Seongmin Cho
Hyeong Yun Kim
Hamin Ban
Joohee Park
Jeongwon Mun
Nayoung Kim
Ji Hun Suh
Yungyeong Shin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454504

113 views

Review

Accepted on 05 Nov 2024

Revolutionizing Head and Neck Squamous Cell Carcinoma Treatment with Nanomedicine in the era of Immunotherapy

in Cancer Immunity and Immunotherapy

Hongxia Li
Yuwen Gong
Pijun Yan
Yong Xu
Gang Qin
Fang-Yuan Teng
Weiping Wen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1453753

Editorial

Published on 05 Nov 2024

Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells

in Cancer Immunity and Immunotherapy

Rosanna Paciucci
Amancio Carnero
Matilde Esther LLeonart

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505225

330 views

Original Research

Accepted on 04 Nov 2024

Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor-Immune Micro-Environment) in distant tumors

in Cancer Immunity and Immunotherapy

Flávia Sardela De Miranda
Dalia Martinez-Marin
Rachel L Babcock
Maribel Castro
Geetha P Boligala
Sonia Y Khan
Kathryn L Furr
Isabel Castro-Piedras
Nicholas Wagner
Dakota E Robison

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498942

134 views

Original Research

Accepted on 04 Nov 2024

A New Perspective on Macrophage-targeted Drug Research: The Potential of KDELR2 in Bladder Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Zhiyi Zhao
Hongling Jia
Zhou Sun
Yumeng Li
Lingyun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485109

102 views

Original Research

Accepted on 04 Nov 2024

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xin Wang
Lang Jiang
Juan Zhao
Mi Wu
Jin Xiong
Xiongwen Wu
Xiufang Weng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456209

Navigation group

Articles

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study

Targeting extracellular matrix stiffness for cancer therapy

The Close Association of Muribaculum and PA (10:0/a-17:0) with the Occurrence of Pancreatic Ductal Adenocarcinoma and Immunotherapy

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study

A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Tertiary lymphoid structures in ovarian cancer

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

Neoantigen prioritization based on antigen processing and presentation

Intratumoral delivery of mRNA encoding the endogenous TLR2/6 agonist UNE-C1 induces immunogenic cell death and enhances antitumor activity

Revolutionizing Head and Neck Squamous Cell Carcinoma Treatment with Nanomedicine in the era of Immunotherapy

Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells

Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor-Immune Micro-Environment) in distant tumors

A New Perspective on Macrophage-targeted Drug Research: The Potential of KDELR2 in Bladder Cancer Immunotherapy

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma